Milk-Derived Peptides

What milk-derived peptides are

Milk proteins, mainly casein and whey, contain short peptide sequences tucked inside the larger protein. A review of food-derived bioactive proteins explains that many such peptides are "encrypted" in intact proteins and released by enzymes during digestion or by fermentation or ripening during food processing, and that those obtained from milk are known in particular. [1] Laboratory and animal studies have described many possible effects, including blood-pressure, bone, immune and antimicrobial effects. [1]

Those are preclinical (cells/animals only) findings unless human trials confirm them. This page looks at the best-studied milk peptide example in people, then at the broader gap between research and products. Milk-derived peptides here means peptides studied from milk, not a claim that milk, yogurt or protein powder acts like a medicine.

The best-studied example: lactotripeptides

Two three-amino-acid peptides, isoleucine-proline-proline (IPP) and valine-proline-proline (VPP), are found in milk products fermented with Lactobacillus helveticus. [1] They are reported to inhibit angiotensin-converting enzyme (ACE), an enzyme involved in blood pressure control. [2] The studies below measured blood pressure, not heart attacks or strokes.

• A well-designed trial found nothing. In a double-blind trial of 135 Dutch adults with raised systolic blood pressure, an 8-week daily dairy drink containing lactotripeptides did not significantly change blood pressure compared with placebo, whether the peptides came from fermented milk, enzyme treatment or chemical synthesis. [3]
• Pooled analysis: small effect. A meta-analysis of 24 studies (28 trials, 1,919 people) found small average reductions in systolic and diastolic blood pressure (1.66 and 0.76 mmHg), described by the authors as statistically significant but small, with inconsistent results between trials. [2]
• Japanese populations: larger effect. A meta-analysis of 18 randomized trials (1,194 Japanese participants) found an average office systolic reduction of 5.63 mmHg, stronger in people with hypertension. [4] The trials differed in design, and the effect appears to relate to baseline blood pressure and population.

Label: mixed. The combined evidence suggests, at most, a small blood-pressure effect in some groups. It does not show that milk peptides replace blood pressure medicine or lower the risk of heart attack or stroke. Do not change a prescribed medicine on the basis of these studies; talk with your prescriber.

Beyond blood pressure

The 2008 review also mentions possible bone effects from a milk basic protein fraction and weaker evidence for immune effects of lactoferrin and for a hemoglobin hydrolysate lowering after-meal triglycerides. [1] These are older, specific findings and have not made milk peptides an established treatment. Label: insufficient evidence.

Research versus products

Research uses defined peptides at tested amounts in controlled trials. Products labeled "casein peptides" or "whey peptides" can be mixtures that differ from the studied ones. A review of regulation notes that human studies are essential before approval as a healthy food, [5] and a 2026 review of bioactive peptides in functional foods describes a significant disconnect between early bioactivity data and demonstrable clinical efficacy. [6] Another review notes poor bioavailability and the lack of correlation between test-tube findings and effects in the body. [7]